Chinese Firms Up Their Game In Novel Flu Antiviral Development

 
• By Dexter Jie Yan
  
flu tablet
domestic commercial rights to three novel flu antivirals changed hands in China in 2023 • Source: Shutterstock
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from China

More from Focus On Asia